| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 04/12/2006 | EP1644371A1 Pyrazoloisoquinoline derivatives as kinase inhibitors |
| 04/12/2006 | EP1644343A1 5-substituted quinazolinone derivatives |
| 04/12/2006 | EP1644337A1 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 04/12/2006 | EP1644325A2 Methods and compositions for treating amyloid-related diseases |
| 04/12/2006 | EP1644012A1 Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in manufacture of medicaments |
| 04/12/2006 | EP1643836A1 Arylmethyl triazolo and imidazopyrazines as c-met inhibitors |
| 04/12/2006 | EP1560826B1 Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same |
| 04/12/2006 | EP1556380B1 Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, preparation thereof and application of same in therapeutics |
| 04/12/2006 | EP1549647B1 Substituted c-imidazo¬1,2-a|pyridin-3-yl-methylamines |
| 04/12/2006 | EP1511747B1 Imidazo-pyridine derivatives as ligands for gaba receptors |
| 04/12/2006 | EP1311499B1 Bicyclic compounds as h3 receptor ligands |
| 04/12/2006 | EP1054887B1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists |
| 04/12/2006 | EP1005356B1 Novel antibacterial agents |
| 04/12/2006 | CN1759116A Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| 04/12/2006 | CN1250553C Antidepressant azaheterocyclylmethyl derivatives of 2, 3-dihydro-1,4-dioxino [2,3-f] quinoxaline |
| 04/12/2006 | CN1250547C Process for extracting matrine and sophoridine from sophora alopecuroide |
| 04/12/2006 | CN1250546C Tetrahydropyrido compound |
| 04/12/2006 | CN1250544C Pyridoarylphenyl oxazolidinone antibacterials and related compositions and methods |
| 04/12/2006 | CN1250531C Novel compounds |
| 04/12/2006 | CN1250222C Praziquantel composition for treating diseases due to sarcocystis, neospora, toxoplasma and isospora |
| 04/12/2006 | CN1250218C Use of angiotensin II antagonists |
| 04/11/2006 | US7026485 inhibitors of HIV protease; N-heterocyclic moiety containing hydroxyethylamine compounds where the heterocyclic moiety may be octahydroisoquinoline |
| 04/11/2006 | US7026484 For therapy of cancer |
| 04/11/2006 | US7026482 Process for preparing imidazoquinolinamines |
| 04/11/2006 | US7026481 Reacting 1,4-dialkylcarboxylate-2,5-bis(N-arylamino)benzene with iodoaryl compound |
| 04/11/2006 | US7026332 Treating obsessive-compulsive disorder, acute stress disorder, post traumatic stress disorder, social anxiety disorder, somatization disorder, specific social phobia, premenstrual dysphoric disorder, and other psychological disorders |
| 04/11/2006 | US7026331 Inhibitors of IkB kinase (I Kappa B Kinase); treating various diseases including asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, cancer, infections, and cardiac infarct |
| 04/11/2006 | US7026312 Substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof |
| 04/11/2006 | US7026134 Contacting the sample with the conjugate and an antibody capable of binding atleast one epitope of oxycodone and its metabolite, and detecting the bound conjugate |
| 04/11/2006 | US7026019 Anisotropic films based on 1,8-naphthoylene-1′,2′-benzimidazole sulfonates and lyotropic liquid crystal systems and methods for making |
| 04/11/2006 | US7025900 Perylenetetracarboxylic acid dibenzimidazole sulfoderivatives containing oxo-groups in the perylene core which form part of a para-quinoid system of bonds, lyotropic liquid crystal systems and anisotropic films containing the same, and methods for making the same |
| 04/11/2006 | CA2411008C Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione |
| 04/11/2006 | CA2329922C Imidazo pyridine derivatives which inhibit gastric acid secretion |
| 04/11/2006 | CA2203619C Crystal growth modifiers for perylene pigments |
| 04/11/2006 | CA2195759C Tetrahydropyridinylmethyl derivatives of pyrrolo[2,3-b]pyridine |
| 04/11/2006 | CA2157128C Camptothecin derivatives, preparations thereof and antitumor agents |
| 04/07/2006 | CA2583572A1 Thiazolyl mglur5 antagonists and methods for their use |
| 04/06/2006 | WO2006036927A1 Crytalline forms of a pyrazolo `3, 4-c ! pyridine factor xa inhibitor |
| 04/06/2006 | WO2006036527A1 Substituted dipiperdine ccr2 antagonists |
| 04/06/2006 | WO2006019965A3 Dipeptidyl peptidase inhibitors |
| 04/06/2006 | US20060074112 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 04/06/2006 | US20060074102 Kinase inhibitors as therapeutic agents |
| 04/06/2006 | US20060074098 Methods of treatment of amyloidosis using ethanolcyclicamine aspartyl protease inhibitors |
| 04/06/2006 | US20060074087 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 04/06/2006 | US20060074068 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions |
| 04/06/2006 | US20060074067 8-(3-pyridinyl)-1-azaspiro[4.5]dec-7-ene; neuroprotectant, analgesic; dysfunction of nicotinic cholinergic neurotransmission, dopamine release, nervous system disorders; drug addiction, obesity; side effect reduction on blood pressure, heart rate, gastro-intestinal tract and skeletal muscle |
| 04/06/2006 | DE102004048729A1 Verfahren zur Herstellung von halogenierten Rylencarbonsäureimiden A process for the preparation of halogenated rylenecarboximides |
| 04/06/2006 | CA2582225A1 Substituted dipiperdine ccr2 antagonists |
| 04/06/2006 | CA2582223A1 Crystalline forms of a pyrazolo '3, 4-c pyridine factor xa inhibitor |
| 04/06/2006 | CA2582222A1 Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones |
| 04/06/2006 | CA2579242A1 Sulfonamides and uses thereof |
| 04/05/2006 | EP1642580A1 Sulfonamide substituted imidazoquinolines |
| 04/05/2006 | EP1642576A2 Methods, kits and compositions for using pyrrole derivatives to combat anxiety |
| 04/05/2006 | EP1641799A1 Imidazo-pyridazinone derivatives and imidazo-pyridone derivatives, production thereof, and use thereof as medicaments |
| 04/05/2006 | EP1641796A1 5ht2c receptor agonists for the treatment of diabetes and obesity |
| 04/05/2006 | EP1641795A1 Triaza- and tetraaza-anthracenedione derivatives, their preparation and their use as pharmaceuticals |
| 04/05/2006 | EP1641794A1 Novel pyrrolodihydroisoquinolines useful in the treatment of cancer |
| 04/05/2006 | EP1641793A1 Novel imidazopyridine compound ii with therapeutic effect |
| 04/05/2006 | EP1641792A1 Pyrrolodihydroisoquinolines as pde10 inhibitors |
| 04/05/2006 | EP1641791A1 3-(guanidinocarbonyl)heterocycle derivatives, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions including them |
| 04/05/2006 | EP1641777A1 Indole derivatives with apoptosis-inducing effect |
| 04/05/2006 | EP1641457A1 Pyrrolo-dihydroisoquinoline derivatives as pde10 inhibitors |
| 04/05/2006 | EP1641455A1 Pyrazolo[3,4-b]pyridin-6-ones as gsk-3 inhibitors |
| 04/05/2006 | EP1641454A1 Pyrazolo[3,4-b]pyridin-6-ones as gsk-3 inhibitors |
| 04/05/2006 | EP1641423A2 Benzodiazepine cgrp receptor antagonists |
| 04/05/2006 | EP1331005B1 Medicinal compositions for concominant use as anticancer atent |
| 04/05/2006 | EP1300398B1 Propane-1,3-dione derivatives |
| 04/05/2006 | EP1294720B1 Non-nucleoside reverse transcriptase inhibitors |
| 04/05/2006 | EP1140192B1 Use of the cyclooxygenase-2 inhibitor celecoxib and capecitabine for combination therapy in neoplasia |
| 04/05/2006 | CN1754880A Process for preparing 2-iminopyrrolidine derivatives |
| 04/05/2006 | CN1249064C Tosylate and benzene sulfonate of pyrazolopy ridone compound |
| 04/05/2006 | CN1249063C Immunoregulatory compounds |
| 04/05/2006 | CN1249062C Substituted imidazopyridines |
| 04/05/2006 | CN1249061C Sulfonamide and sulfamide substituted imidazoquinolines and its pharmaceutical composition and uses |
| 04/05/2006 | CN1249051C Muscarinic agonists |
| 04/05/2006 | CN1249034C Novel derivative of 2-azadicyclo-(2,2,1) heptane, its preparation and uses |
| 04/05/2006 | CN1248692C Use of corpus vitreum conjugated protein receptor antagon in preparation of medicine for inhibiting accretion generation |
| 04/04/2006 | US7022856 Carboline derivatives |
| 04/04/2006 | US7022849 Quinazoline and pyrido[2,3-d]pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 04/04/2006 | US7022734 Use of a transition metal complex, other than deferoxamine-manganese, hemin, diethyldithiocarbamic acid complexes or an iron hemoprotein, in the manufacture of a medicament for the therapy of septic shock |
| 04/04/2006 | US7022729 For treating central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives |
| 04/04/2006 | US7022711 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido[2,3-d]pyrimidin-7-ones |
| 04/04/2006 | US7022706 Central nervous system disorders |
| 04/04/2006 | US7022701 for treatment of disorders (sleeping, feeding) relating to or affected by the 5-HT6 receptor; serotonin receptor antagonists |
| 04/04/2006 | US7022697 4-(Oxadiazol-3-yl)-1,4-diazabicyclo[3.2.2]-nonane derivatives, preparation and therapeutic use thereof |
| 04/04/2006 | US7022312 Condensation aerosol as doage forms, is produced by heating a thin layer containing of dolasetron, granisetron or metoclopramide to form vapor, condense into an aerosol; fast producing peak plasma concentrations |
| 04/04/2006 | US7022259 include cyclic group chain structures similar to the liquid crystal to serve as the core structure, and multi-ring structures of natural alcohol with optical activity, such as alcoholates of terpenol, borneol, cinchonidine, quinine, or their derivatives; have a high helical twisting power |
| 04/04/2006 | CA2356544C Pyridotriazines and pyridopyridazines |
| 04/04/2006 | CA2198266C Novel benzimidazole derivatives |
| 04/04/2006 | CA2166315C Process for the preparation of thalidomide |
| 04/04/2006 | CA2043976C Substituted phthalides and heterocyclic phthalides |
| 03/30/2006 | WO2006034113A2 Quinolone analogs as cell proliferation inhibitors |
| 03/30/2006 | WO2006034090A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
| 03/30/2006 | WO2006034015A1 (spirocyclylamido) aminothiophene compounds as c-kit proto- oncogene inhibitors |
| 03/30/2006 | WO2006033796A1 SUBSTITUTED PYRAZOLO [1,5-a] PYRIMIDINES AND PROCESS FOR MAKING SAME |
| 03/30/2006 | WO2006033703A1 Imidazo[4,5-d]pyrimidines, their uses and methods of preparation |
| 03/30/2006 | WO2006033422A1 Quinolizinone compound and use thereof as hiv integrase inhibitor |
| 03/30/2006 | WO2006032994A2 Muscarinic receptor antagonists |
| 03/30/2006 | WO2006032470A1 Compounds which increase apolipoprotein a-1 production and uses thereof in medicine |
| 03/30/2006 | WO2005123089A3 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |